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Abstract 
Neutrophils play an important role in the lung tumour microenvironment. We 
hypothesised that radiolabelled neutrophils coupled to single-photon emission 
computed tomography (SPECT) may non-invasively quantify neutrophil uptake in 
tumours from patients with non-small cell lung cancer. We demonstrated increased 
uptake of radiolabelled neutrophils from the blood into tumours compared to non-
specific uptake using radiolabelled transferrin. Moreover, In-111-neutrophil activity 
in the tumour biopsies also correlated with MPO-positive neutrophils. Our data 
support the utility of imaging with In-111-labelled neutrophils and SPECT-CT to 
quantify neutrophil uptake in lung cancer. 
Introduction
Lung cancer is the leading cause of cancer-related death worldwide. Inflammation has 
emerged as a hallmark of tumourigenesis, contributing to the development and 
progression of a range of cancers. Neutrophils are known to be important players in 
the tumour microenvironment and these tumour-associated neutrophils (TANs) are 
broadly classified into an N1 tumour-suppressing phenotype or an N2 tumour-
promoting phenotype. While neutrophils may exert both pro- and anti-tumoural 
functions, the prevailing view is that they serve to exclude T cell access and hence 
promote tumour progression. In murine studies, Ly-6G-specific depletion of 
neutrophils reduced the metastatic burden in the lungs,[1] while in kras-driven mouse 
models of lung cancer, Gr1+ neutrophils were found to favour tumour growth, reduce 
T cell homing, and antagonise anti-PD1 immunotherapy.[2] Furthermore, neutrophil 
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derived mediators have been shown to be pro-tumourigenic; neutrophil elastase 
contributes to tumour proliferation,[3] MMP-9 increases VEGF release (from the 
ECM) to promote angiogenesis,[4] and neutrophil extracellular traps (NETs) can 
sequester circulating tumour cells in the pulmonary microvasculature, promoting the 
development of metastasis.[5]
Although evidence exists that infiltrating neutrophils accumulate in NSCLC,[6] 
direct non-invasive imaging and quantification of neutrophils within patient tumours 
has never been described. Such quantification could aid in predicting the therapeutic 
response and clinical outcome of patients. Here we describe quantitative SPECT-CT 
using indium-111-radiolabelled autologous neutrophils to quantify neutrophil uptake 
in tumours of patients with early stage lung cancer, using indium-labelled transferrin 
as a marker for non-specific uptake of non-cell-bound activity. We also correlated 
tissue concentrations of radiolabelled neutrophils with histological evidence of 
MPO+ neutrophils. These findings have important implications for the use of 
quantitative SPECT-CT to monitor the extent of neutrophil uptake by tumours.
Clinical Cases 
Six patients were selected for entry into the study met the following criteria: (i) 
Positron Emission Tomography or biopsy confirmed pre-operative stage I-II lung 
cancer in the mid-upper zones of the lung, (ii) no prior chemo- or radio-therapy, and 
(iii) no other active malignancy. Biopsies were performed ≥ 1 month prior to 
acquisition of SPECT images. Tumours in the mid-upper zones were chosen to avoid 
potential overlap of the signal with physiological uptake of radiolabelled cells in the 
liver. Patient characteristics can be found in Supplementary Table 1 and the study 
protocol is summarised in Supplementary Figure 1. 
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In four volunteers, neutrophils were isolated from peripheral venous blood using 
plasma-Percoll gradients and radiolabelled with indium-111-tropolonate, as described 
in Supplementary Methods. Given that increased vascularity of tumours could 
contribute to enhanced uptake of In-111-neutrophils,[7] we also assessed the uptake 
of In-111-transferrin into tumours. Transferrin can be taken up by tumours non-
specifically through highly permeable blood vessels. Hence, in two further patients, 
In-111-transferrin was prepared as a control for non-specific uptake (Supplementary 
Methods), so that specific focal accumulation of In-111-neutrophils in the tumour area 
can be compared.
Over 40 min of dynamic gamma camera imaging, labelled neutrophils displayed 
physiological kinetics in liver, lungs and spleen, in line with previous results from 
healthy volunteers (Supplementary Fig. 2A).[8] The recoveries of radiolabelled 
neutrophils from the peripheral blood 45-min after injection (Supplementary Fig. 2B) 
were comparable to published data, indicating that the cells were not activated by 
isolation and radiolabelling. As expected, In-111-transferrin behaved as a labelled 
plasma protein (Supplementary Figs. 2A and B). 
SPECT-CT showed very clear and evident uptake of neutrophils into the tumour of a 
patient with squamous cell carcinoma (Case 1; Figs. 1A-1D).  As shown in Fig 1E, 
tumour uptake increased in patients with injected In-111-neutrophils with a median of 
0.0038 mL/min/mL (IQR; 0.0231-0.0531) compared with a median of 0.0009 
mL/min/mL for In-111-transferrin (IQR; 0.0004-0.0013). SPECT-CT with attenuation 
correction (Fig 1F) showed an overall increase in In-111-neutrophil clearance into 
tumour with a median of 0.0103 mL/min/mL (IQR; 0.0021-0.0387) compared with a 
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median of 0.0037 mL/min/mL for In-111-transferrin clearance (IQR; 0.0008-0.0066). 
Of note, SPECT-CT without attenuation correction increased In-111-neutrophil 
clearance compared to In-111-transferrin clearance in all four patients, but only in two 
patients following attenuation correction. Attenuation correction of SPECT images is 
known to improve quantitative accuracy of malignant lesions in the body by reducing 
soft tissue artefacts.[9] Therefore, we propose that the attenuation corrected values 
provide a more representative quantification of neutrophil clearance.  
The median peripheral neutrophil count was higher in the In-111 neutrophil patient 
group compared to the In-111 transferrin group (Supplementary Table 1); however 
the correlation coefficient between the neutrophil count and the non-attenuation 
corrected Patlak-Rutland slope (r=0.6, p=0.24) or the attenuation corrected Patlak-
Rutland slope (r=0.20, p=0.71) was not significant for the 6 cases.
On cell counting of tissue ex vivo, Case 1 displayed substantial accumulation of 
neutrophils in the centre (median 21 MPO+ neutrophils per hpf (IQR; 14-35) and 
periphery (median 19 MPO+ neutrophils per hpf (IQR; 15-29) of the tumour 
compared to the background parenchyma (median 5 MPO+ neutrophils per hpf (IQR; 
4-11) (Figs. 1G and 1H). Similar findings were obtained in one further patient with a 
squamous cell carcinoma (Supplementary Fig. 3). There was no discernible neutrophil 
infiltration at the tumour centre or periphery in the patient with adenocarcinoma 
(Supplementary Fig. 3). When all four cases were combined, the radiolabelled 
neutrophil gamma counts positively correlated with the number of MPO+ neutrophils 
(Fig. 1I; r=0.50, 95% CI: 0.291-0.666; p<0.0001). Of interest, neutrophils were 
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detected by IHC when the gamma radiation counts were low, suggesting the presence 
of tissue resident neutrophils.
Discussion
In the present study, we demonstrated quantitative in vivo SPECT-CT imaging of 
radiolabelled neutrophil uptake in tumours of patients with lung cancer. Our study 
also established that MPO+ neutrophils in lung resections correlated with 
radiolabelled neutrophil counts. Such a non-invasive imaging strategy could have 
important implications for monitoring neutrophil infiltration into tumours, and 
assessing the impact of neutrophil-targeted therapies in NSCLC.
Two previous studies have reported enhanced uptake of In-111 mixed leukocytes and 
In-111 granulocytes into a number of localised malignant neoplasms such as 
pulmonary sarcoma, albeit without quantitative measurements and a subjective 
scoring protocol.[10,11] There is current interest in quantifying tissue concentration 
of single-photon emitting tracers using attenuation-corrected SPECT-CT, with the aim 
of bringing SPECT-CT in line with PET-CT; we believe ours is the first attempt to do 
so in cell trafficking studies. The importance of our approach lies in the ability to fully 
exploit techniques such as Patlak-Rutland analysis, which, as in PET-CT, rely on 
absolute tissue quantification. In our previous studies of neutrophil trafficking in lung 
tissue, we circumvented this by normalising the Patlak-Rutland slope to the intercept 
of the plot, which reflects distribution volume of tracer in the tissue (the marginated 
pulmonary neutrophil pool). However, in solid tissue such as tumour, the quantitative 
nature of the intercept is uncertain. Quantitative SPECT-CT has general value in 
studies based on labelled neutrophils because quantification of neutrophil 
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accumulation in enclosed spaces, like abscesses (as opposed to open tracts), uses 
crude indices such as abscess/background ratios at arbitrarily selected time points 
post-injection.
Of interest, we observed inter-tumour heterogeneity with respect to neutrophil uptake 
into tumours by both imaging and immunohistochemistry approaches, consistent with 
previous immunohistochemistry studies. A larger scale study will be required to 
understand the prognostic implication of such variable neutrophil infiltration. Some 
authors have suggested that, in addition to neutrophil abundance, the specific location 
of neutrophils within the tumour has prognostic relevance. Sody et al., using a murine 
model of neutrophil trafficking, found that neutrophils exhibit distinct migratory 
patterns depending on their localisation to intra-tumoural or peri-tumoural 
regions.[12] 
Given the broadly pro-tumourigenic role of neutrophils, modulation of neutrophil 
migration into tumours is an attractive therapeutic approach in NSCLC. Indeed, 
targeting neutrophil recruitment may be beneficial as adjuvant therapy. The CXCR2 
pathway has a major role in the control of neutrophil recruitment into tumours, and 
antagonists of the CXCR2 receptor have reduced tumour growth in murine studies. 
Phase II clinical trials using CXCR2 inhibitors in NSCLC patients are on-going. 
[13] Our findings thus offer the prospect of imaging neutrophils in clinical trials to 
better understand the therapeutic response of targeting neutrophils.
Our study has several limitations. First, our results are drawn from a small sample 
size, and follow-up will be required to confirm the utility of neutrophil imaging in 
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NSCLC. Second, as tumour-associated neutrophils exhibit significant heterogeneity, 
our study could not detect the maturity or activation status of the trafficked cells. 
Third, there are reports of increased transferrin receptor expression on lung cancer 
cells,[14] which could limit the use of radiolabelled transferrin as a negative control. 
However, as both radiolabelled transferrin and radiolabelled neutrophils are injected 
in plasma, this will likely increase the baseline uptake in both cases.   
In conclusion, we demonstrate how radiolabeled neutrophils and SPECT-CT can be 
combined to allow non-invasive quantification of neutrophil accumulation in lung 
cancer. Further studies of in vivo neutrophil trafficking in NSCLC are warranted.
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Figure 1. Quantification of radiolabelled neutrophils and radiolabelled 
transferrin in lung tumours of patients with early stage lung cancer. 
SPECT-CT images showing A) transaxial, B) coronal with 3D reconstruction of 
tumour, C) sagittal and D) coronal plane from a patient with squamous cell carcinoma 
(Case 1). Images show accumulation in the tumour (outlined in green) and 
physiological uptake in the liver (L), spleen (S) and vertebra (V) 20 hours after 
reinjection of In-111-labelled neutrophils. E) and F) Quantification of tumour uptake 
of In-111-labelled neutrophils (Cases 1-4) and In-111-labelled transferrin (Cases A 
and B) using non-attenuation corrected (E) and attenuation corrected values (F). G) 
Tissue gamma counts and MPO+ neutrophil counts from the background parenchyma, 
peri-tumoural parenchyma, tumour periphery, and tumour centre of a subject with 
squamous cell carcinoma (Case 1). H) Background parenchyma and tumour centre 
cores from Case 1 (upper panels) alongside representative MPO 
immunohistochemical staining (lower panels). Magnification x400. I) Correlation 
between gamma radiation counts and MPO+ neutrophil counts in four subjects. MPO+ 
neutrophils were counted in four high powered fields. Correlation coefficients were 
calculated using Spearman correlation analysis.
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Suppl. Figure 3
Case 2 (Squamous cell carcinoma)  
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Supplementary Methods, Tables and Figures 
 
Neutrophil and transferrin radiolabelling  
In four volunteers, neutrophils were isolated from peripheral venous blood using plasma-
Percoll gradients (GE Healthcare, Buckinghamshire, United Kingdom) and radiolabelled with 
indium-111-tropolone, as described.[1] Briefly, 80 mL of blood was collected in 5% acid 
citrate dextrose be ore erythrocyte sedimentation using 5% hydroxyethylstarch (Grifols). 
After sedimentation, the upper layer of leukocytes was resusupended in 2 mL cell-free 
plasma before over layering onto Percoll iso-osmotic gradients (50%, 60%, and 65%) diluted 
in cell-free plasma. After centrifugation for 5 min at 150g the neutrophil layer was removed 
from the lower gradient interface before resuspension in cell free plasma and incubation with 
In-111 (Covidien Healthcare, Fareham, UK) and tropolone (0.054% w/v; Ipswich Pharmacy 
Manufacturing Unit, Ipswich UK) for 10 min. Prior to radiolabelling, a sample of the 
neutrophil layer was cytocentrifuged to assess the purity of the isolated fraction (≥95% 
neutrophil purity, with eosinophils and monocytes being the main contaminating cell types). 
The recovery of In-111-neutrophils from the peripheral blood was measured 45 min after 
injection.[2]  
 
In two further patients, In-111-transferrin was prepared as a control for non-specific uptake 
from 40 mL of autologous venous blood, as described.[3] 
 
Planar dynamic and SPECT-CT imaging 
Participants were positioned in a double-headed SPECT-CT camera (GE Discovery 670, GE 
Healthcare), fitted with medium-energy, parallel-hole collimators. After bolus injection of 
indium-111-labelled neutrophils (median 12.9; interquartile range 10.4-14.8 MBq) or indium-
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111-labelled transferrin (median 12.1; interquartile range 9.6-14.5 MBq) into an antecubital 
fossa vein, activities in the chest and upper abdomen were recorded over 40 min.[4] SPECT 
images were acquired at 1, 4 and 20 h following injection. A single low-dose CT was 
performed at 45 min. Supplementary Fig.1 summarises the study design.  
 
Patlak-Rutland analysis 
Patlak-Rutland analysis allows the quantification of the clearance of a tracer from the blood 
compartment into the tissue. It plots the ratio of tissue-to-blood concentration at known time 
points after tracer injection against normalised time, which is a derivative of blood 
concentration. The slope of the plot represents tracer clearance.  
 
Peripheral blood samples were taken at 2, 4, 6, 8, 10, 15, 30, 45, 90, 120, 240, 360, and 1200 
min after injection. Regions of interest were drawn on SPECT-CT images. As previously 
described for whole lung neutrophil clearance, Patlak-Rutland was used to measure In-111-
neutrophil and In-111-transferrin clearances from the blood into tumours.[4] For the first time 
in relation to labelled blood cell trafficking, attenuation correction was performed using 
Volumetrix (Version MI, GE Healthcare) and SPECT-CT co-registration using 3D Slicer 
(Version 4.10.1, NIH). Co-registration of the SPECT images before reconstruction used 
iterative reconstruction (OSEM 2 iterations 10 subsets). Clearances were then expressed 
without and with attenuation correction, the latter giving clearance in real units of 
mL/min/mL.  
 
Tissue quantification of radiolabelled neutrophils  
Punch biopsy cores (4 mm) were taken from formalin-fixed resected tumours ≤24 h after 
surgery. Cores were taken from the background parenchyma, peri-tumoural parenchyma, 
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tumour periphery and tumour centre. The number of cores collected from each case is shown 
in Supplementary Table 2; core number was dependent on lobe size. Furthermore, care was 
taken to ensure enough samples were available for tumour, node and staging classification. 
After collection the cores were measured in a gamma counter (Wallac 1480, Perkin Elmer, 




Four micrometer tissue sections were incubated with polyclonal rabbit anti-human 
myeloperoxidase antibody (Dako Cytomation, Ely, UK), labelled using dextran-coupled 
peroxidase and 3-3’diaminobenzidine (Dako Cytomation, Ely, UK), and counterstained with 
haematoxylin. MPO+ neutrophils were counted in a blinded manner.  
 
Statistical analysis 
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Table S1. Patients and tumour characteristics.  
Data are presented as median with the interquartile range in brackets. Tumour, node and 
metastasis staging was classified using The Eighth Edition Lung Cancer Stage 
Classification.[5]  
 




N 4 2 
Age (y)  72 (69-74) 75 (71-79) 
Sex: male/female 3/1 1/1 
Peripheral blood neutrophil 
count (x109/L)  












Stage Ib (1) 
Stage IIb (2) 
Stage IIIa (1) 
Stage IIa (1) 
Stage IIb (1) 
Tumour grade T2a (2), T2b (2) T2b (2) 
Nodal stage N0 (3), N2 (1) N0 (2) 
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Supplemenray Figure legends 
 
Supplementary Figure 1. Summary of study protocol.  
Schematic diagram of the study protocol. Four patients were imaged using In-111 radio-
labelled neutrophils and two patients with In-111 radio-labelled transferrin. Lobectomy was 
performed ≥24 hours following the final SPECT/planar scan. SPECT, single-photon emission 
computed tomography.  
 
Supplementary Figure 2. Dynamic planar imaging in patients with resectable lung 
cancer.  
A) Distribution of radioactivity over 20 h for the right lung (green), left lung (orange), liver 
(pink), spleen (red) and right ventricle (blue) after reinjection of In-111-labelled neutrophils 
(left) or In-111-labelled transferrin (right). Data show median and interquartile range. B) 
Proportion of In-111-labelled neutrophils (n=4) and In-111-labelled transferrin (n=2) 
remaining in the blood 45 minutes after reinjection.  
 
Supplementary Figure 3. In-111-labelled neutrophil radioactivity and MPO+ neutrophil 
counts in resected lungs.  
Tissue gamma counts and MPO+ neutrophil counts from the background parenchyma, 
peritumoural parenchyma, tumour periphery, and tumour centre from Patients 2, 3, and 4.  
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Supplementary Methods, Tables and Figures 
 
Neutrophil and transferrin radiolabelling  
In four volunteers, neutrophils were isolated from peripheral venous blood using plasma-
Percoll gradients (GE Healthcare, Buckinghamshire, United Kingdom) and radiolabelled with 
indium-111-tropolone, as described.[1] Briefly, 80 mL of blood was collected in 5% acid 
citrate dextrose before erythrocyte sedimentation using 5% hydroxyethylstarch (Grifols). 
After sedimentation, the upper layer of leukocytes was resusupended in 2 mL cell-free 
plasma before over layering onto Percoll iso-osmotic gradients (50%, 60%, and 65%) diluted 
in cell-free plasma. After centrifugation for 5 min at 150g the neutrophil layer was removed 
from the lower gradient interface before resuspension in cell free plasma and incubation with 
In-111 (Covidien Healthcare, Fareham, UK) and tropolone (0.054% w/v; Ipswich Pharmacy 
Manufacturing Unit, Ipswich UK) for 10 min. Prior to radiolabelling, a sample of the 
neutrophil layer was cytocentrifuged to assess the purity of the isolated fraction (≥95% 
neutrophil purity, with eosinophils and monocytes being the main contaminating cell types). 
The recovery of In-111-neutrophils from the peripheral blood was measured 45 min after 
injection.[2]  
 
In two further patients, In-111-transferrin was prepared as a control for non-specific uptake 
from 40 mL of autologous venous blood, as described.[3] 
 
Planar dynamic and SPECT-CT imaging 
Participants were positioned in a double-headed SPECT-CT camera (GE Discovery 670, GE 
Healthcare), fitted with medium-energy, parallel-hole collimators. After bolus injection of 
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111-labelled transferrin (median 12.1; interquartile range 9.6-14.5 MBq) into an antecubital 
fossa vein, activities in the chest and upper abdomen were recorded over 40 min.[4] SPECT 
images were acquired at 1, 4 and 20 h following injection. A single low-dose CT was 
performed at 45 min. Supplementary Fig.1 summarises the study design.  
 
Patlak-Rutland analysis 
Patlak-Rutland analysis allows the quantification of the clearance of a tracer from the blood 
compartment into the tissue. It plots the ratio of tissue-to-blood concentration at known time 
points after tracer injection against normalised time, which is a derivative of blood 
concentration. The slope of the plot represents tracer clearance.  
 
Peripheral blood samples were taken at 2, 4, 6, 8, 10, 15, 30, 45, 90, 120, 240, 360, and 1200 
min after injection. Regions of interest were drawn on SPECT-CT images. As previously 
described for whole lung neutrophil clearance, Patlak-Rutland was used to measure In-111-
neutrophil and In-111-transferrin clearances from the blood into tumours.[4] For the first time 
in relation to labelled blood cell trafficking, attenuation correction was performed using 
Volumetrix (Version MI, GE Healthcare) and SPECT-CT co-registration using 3D Slicer 
(Version 4.10.1, NIH). Co-registration of the SPECT images before reconstruction used 
iterative reconstruction (OSEM 2 iterations 10 subsets). Clearances were then expressed 
without and with attenuation correction, the latter giving clearance in real units of 
mL/min/mL.  
 
Tissue quantification of radiolabelled neutrophils  
Punch biopsy cores (4 mm) were taken from formalin-fixed resected tumours ≤24 h after 




































































Confidential: For Review Only
 3 
tumour periphery and tumour centre. The number of cores collected from each case is shown 
in Supplementary Table 2; core number was dependent on lobe size. Furthermore, care was 
taken to ensure enough samples were available for tumour, node and staging classification. 
After collection the cores were measured in a gamma counter (Wallac 1480, Perkin Elmer, 




Four micrometer tissue sections were incubated with polyclonal rabbit anti-human 
myeloperoxidase antibody (Dako Cytomation, Ely, UK), labelled using dextran-coupled 
peroxidase and 3-3’diaminobenzidine (Dako Cytomation, Ely, UK), and counterstained with 
haematoxylin. MPO+ neutrophils were counted in a blinded manner.  
 
Statistical analysis 
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Table S1. Patients and tumour characteristics.  
Data are presented as median with the interquartile range in brackets. Tumour, node and 
metastasis staging was classified using The Eighth Edition Lung Cancer Stage 
Classification.[5]  
 




N 4 2 
Age (y)  72 (69-74) 75 (71-79) 
Sex: male/female 3/1 1/1 
Peripheral blood neutrophil 
count (x109/L)  












Stage Ib (1) 
Stage IIb (2) 
Stage IIIa (1) 
Stage IIa (1) 
Stage IIb (1) 
Tumour grade T2a (2), T2b (2) T2b (2) 
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Supplemenray Figure legends 
 
Supplementary Figure 1. Summary of study protocol.  
Schematic diagram of the study protocol. Four patients were imaged using In-111 radio-
labelled neutrophils and two patients with In-111 radio-labelled transferrin. Lobectomy was 
performed ≥24 hours following the final SPECT/planar scan. SPECT, single-photon emission 
computed tomography.  
 
Supplementary Figure 2. Dynamic planar imaging in patients with resectable lung 
cancer.  
A) Distribution of radioactivity over 20 h for the right lung (green), left lung (orange), liver 
(pink), spleen (red) and right ventricle (blue) after reinjection of In-111-labelled neutrophils 
(left) or In-111-labelled transferrin (right). Data show median and interquartile range. B) 
Proportion of In-111-labelled neutrophils (n=4) and In-111-labelled transferrin (n=2) 
remaining in the blood 45 minutes after reinjection.  
 
Supplementary Figure 3. In-111-labelled neutrophil radioactivity and MPO+ neutrophil 
counts in resected lungs.  
Tissue gamma counts and MPO+ neutrophil counts from the background parenchyma, 
peritumoural parenchyma, tumour periphery, and tumour centre from Patients 2, 3, and 4.  
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